Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,483.54
+22.71 (1.55%)
At close: Nov 12, 2026
EGX:AXPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 7,418 | 5,595 | 2,228 | 1,054 | 691 | 529 | |
Market Cap Growth | 84.98% | 151.12% | 111.49% | 52.48% | 30.54% | -21.61% |
Enterprise Value | 7,030 | 5,186 | 2,058 | 916 | 546 | 489 |
Last Close Price | 1483.54 | 1119.09 | 414.37 | 177.60 | 107.31 | 74.62 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 15.97 | 10.66 | 5.70 | 4.86 | 5.47 | 4.51 |
Forward PE | - | 4.57 | 4.57 | 4.57 | 4.57 | 4.57 |
PS Ratio | 2.33 | 1.76 | 0.81 | 0.60 | 0.47 | 0.48 |
PB Ratio | 6.29 | 4.75 | 2.24 | 1.33 | 1.05 | 0.86 |
P/TBV Ratio | 6.29 | 4.75 | 2.24 | 1.33 | 1.05 | 0.86 |
P/FCF Ratio | 17.15 | 12.94 | 7.28 | 8.27 | 97.40 | 3.29 |
P/OCF Ratio | 14.22 | 10.73 | 6.63 | 5.56 | 7.57 | 2.75 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 2.21 | 1.63 | 0.75 | 0.52 | 0.37 | 0.45 |
EV/EBITDA Ratio | 9.75 | 7.19 | 3.76 | 3.00 | 2.99 | 3.10 |
EV/EBIT Ratio | 10.45 | 7.71 | 4.08 | 3.43 | 3.53 | 3.64 |
EV/FCF Ratio | 16.26 | 11.99 | 6.72 | 7.19 | 77.01 | 3.04 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.07 | 0.06 |
Debt / FCF Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 1.70 | 0.06 |
Net Debt / Equity Ratio | -0.33 | -0.33 | -0.28 | -0.19 | -0.12 | -0.24 |
Net Debt / EBITDA Ratio | -0.54 | -0.54 | -0.51 | -0.49 | -0.43 | -0.92 |
Net Debt / FCF Ratio | -0.90 | -0.90 | -0.92 | -1.17 | -11.06 | -0.90 |
Asset Turnover | 1.93 | 1.93 | 2.00 | 1.63 | 1.65 | 1.32 |
Inventory Turnover | 4.13 | 4.13 | 3.70 | 3.16 | 3.97 | 3.03 |
Quick Ratio | 1.25 | 1.25 | 0.96 | 0.69 | 0.75 | 1.15 |
Current Ratio | 2.28 | 2.28 | 2.21 | 1.97 | 2.34 | 2.35 |
Return on Equity (ROE) | 48.29% | 48.29% | 43.72% | 29.78% | 19.87% | 19.59% |
Return on Assets (ROA) | 25.45% | 25.45% | 22.79% | 15.45% | 10.77% | 10.08% |
Return on Invested Capital (ROIC) | 70.60% | 68.88% | 57.12% | 33.49% | 22.63% | 21.93% |
Return on Capital Employed (ROCE) | 56.60% | 56.60% | 50.30% | 33.20% | 23.00% | 21.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 6.26% | 9.38% | 17.55% | 20.57% | 18.30% | 22.18% |
FCF Yield | 5.83% | 7.73% | 13.74% | 12.09% | 1.03% | 30.40% |
Dividend Yield | 4.25% | 5.63% | 14.13% | 14.24% | 9.41% | - |
Payout Ratio | 65.44% | 65.44% | 44.40% | 37.83% | 60.86% | 54.95% |
Buyback Yield / Dilution | -5.18% | -5.18% | -7.39% | - | - | - |
Total Shareholder Return | -0.94% | 0.45% | 6.74% | 14.24% | 9.41% | - |